[go: up one dir, main page]

WO2003039270A1 - Antiobestic foods and drinks - Google Patents

Antiobestic foods and drinks Download PDF

Info

Publication number
WO2003039270A1
WO2003039270A1 PCT/JP2002/011608 JP0211608W WO03039270A1 WO 2003039270 A1 WO2003039270 A1 WO 2003039270A1 JP 0211608 W JP0211608 W JP 0211608W WO 03039270 A1 WO03039270 A1 WO 03039270A1
Authority
WO
WIPO (PCT)
Prior art keywords
antiobestic
foods
drinks
acceptable salts
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/011608
Other languages
French (fr)
Japanese (ja)
Inventor
Hisami Shinohara
Gou Shinohara
Noriyasu Kuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oillio Group Ltd
Original Assignee
Nisshin Oillio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oillio Ltd filed Critical Nisshin Oillio Ltd
Priority to JP2003541376A priority Critical patent/JPWO2003039270A1/en
Publication of WO2003039270A1 publication Critical patent/WO2003039270A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Antiobestic foods and drinks containing compounds selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts thereof and derivatives of the same, in particular, antiobestic foods and drinks containing maslinic acid and/or physiologically acceptable salts thereof.
PCT/JP2002/011608 2001-11-08 2002-11-07 Antiobestic foods and drinks Ceased WO2003039270A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003541376A JPWO2003039270A1 (en) 2001-11-08 2002-11-07 Anti-obesity food and drink

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001343917 2001-11-08
JP2001-343917 2001-11-08

Publications (1)

Publication Number Publication Date
WO2003039270A1 true WO2003039270A1 (en) 2003-05-15

Family

ID=19157516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/011608 Ceased WO2003039270A1 (en) 2001-11-08 2002-11-07 Antiobestic foods and drinks

Country Status (3)

Country Link
JP (1) JPWO2003039270A1 (en)
TW (1) TW200300069A (en)
WO (1) WO2003039270A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508284A (en) * 2004-07-29 2008-03-21 ミシガン ステイト ユニバーシティー Methods and compositions for treating obesity, insulin related diseases, and hypercholesterolemia
WO2009121992A2 (en) 2008-04-03 2009-10-08 Biomaslinic S.L. Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
JP2010503644A (en) * 2006-09-18 2010-02-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック Use of quinoa extract as a cosmetic and slimming agent and / or to prevent the formation of new fat in the human body
JP2010202558A (en) * 2009-03-02 2010-09-16 Nihon Univ Antiobestic agent and diabetes-ameliorating agent
JP2011236150A (en) * 2010-05-10 2011-11-24 Nippon Flour Mills Co Ltd Antiallergic agent comprising maslinic acid as active ingredient
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
WO2018051471A1 (en) * 2016-09-15 2018-03-22 日本農産工業株式会社 Fat accumulation inhibitor, preadipocyte differentiation inhibitor, visceral-fat-reducing agent, and food or beverage for visceral-fat reduction

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967249A (en) * 1995-06-22 1997-03-11 Nippon Flour Mills Co Ltd Glycerophosphate dehydrogenase inhibitor
JP2000044478A (en) * 1998-07-28 2000-02-15 Pola Chem Ind Inc Acat-inhibitor and composition containing the same for preventing and curing arteriosclerosis
JP2000136130A (en) * 1998-10-30 2000-05-16 Coral Biotech Kk Suppressant for liberation of histamine
JP2001224309A (en) * 2000-02-10 2001-08-21 Nisshin Oil Mills Ltd:The Edible oil-and-fat having function to ameliorate lipid in blood
JP2001252054A (en) * 2000-01-07 2001-09-18 Kanebo Ltd Food composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967249A (en) * 1995-06-22 1997-03-11 Nippon Flour Mills Co Ltd Glycerophosphate dehydrogenase inhibitor
JP2000044478A (en) * 1998-07-28 2000-02-15 Pola Chem Ind Inc Acat-inhibitor and composition containing the same for preventing and curing arteriosclerosis
JP2000136130A (en) * 1998-10-30 2000-05-16 Coral Biotech Kk Suppressant for liberation of histamine
JP2001252054A (en) * 2000-01-07 2001-09-18 Kanebo Ltd Food composition
JP2001224309A (en) * 2000-02-10 2001-08-21 Nisshin Oil Mills Ltd:The Edible oil-and-fat having function to ameliorate lipid in blood

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508284A (en) * 2004-07-29 2008-03-21 ミシガン ステイト ユニバーシティー Methods and compositions for treating obesity, insulin related diseases, and hypercholesterolemia
EP1771188A4 (en) * 2004-07-29 2010-04-21 Univ Michigan State METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN-ASSOCIATED DISEASES, AND HYPERCHOLESTEROLEMIA
US7772195B2 (en) * 2004-07-29 2010-08-10 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
JP2010503644A (en) * 2006-09-18 2010-02-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック Use of quinoa extract as a cosmetic and slimming agent and / or to prevent the formation of new fat in the human body
WO2009121992A2 (en) 2008-04-03 2009-10-08 Biomaslinic S.L. Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
JP2010202558A (en) * 2009-03-02 2010-09-16 Nihon Univ Antiobestic agent and diabetes-ameliorating agent
JP2011236150A (en) * 2010-05-10 2011-11-24 Nippon Flour Mills Co Ltd Antiallergic agent comprising maslinic acid as active ingredient
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
WO2018051471A1 (en) * 2016-09-15 2018-03-22 日本農産工業株式会社 Fat accumulation inhibitor, preadipocyte differentiation inhibitor, visceral-fat-reducing agent, and food or beverage for visceral-fat reduction

Also Published As

Publication number Publication date
TW200300069A (en) 2003-05-16
JPWO2003039270A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
WO2002043736A1 (en) Beautifying foods and drinks and peroral beautifying preparations
AU5397699A (en) Pasteurized or ultra-pasteurized complete nutritional compositions and products
IL210824A0 (en) [1,2,4] TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
AU3696599A (en) Esterified and subsequently hydrogenated phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
AU4549499A (en) Polyurea-based adhesives, articles therefrom, and methods of their preparation and use
EP1183954A4 (en) Fading inhibitors
AU2003259112A1 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
AU2003223989A1 (en) System for orally administering active substances, vitamins and/or foodstuffs
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
ZA200002610B (en) Flavor compounds.
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001257309A1 (en) Lactic acid food products
WO2003039270A1 (en) Antiobestic foods and drinks
WO2000067696A3 (en) Lactic acid bacteria with anxiolytic properties and uses thereof
AU7032700A (en) Low potassium juice, method for producing thereof and food containing the same
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
WO2002026717A8 (en) Hydroxy acid integrin antagonists
AU2003260566A1 (en) Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
AU2001272695A1 (en) Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it
AU5483500A (en) Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
AU2003265091A1 (en) Coffee extracts, their use as flavoring ingredients and as instant coffee type products
AU4544600A (en) Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003541376

Country of ref document: JP

122 Ep: pct application non-entry in european phase